MDCX logo
MDCX NASDAQ US

Medicus Pharma Ltd. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 2023
$0.45
▲ +$0.03 (+6.43%)
Vol 575K
4
Quality Score
fail
Mkt Cap
$38.4M
ROE
-277.3%
D/E
9.99
Beta
0.73
52W
$1–$9

Wall Street Consensus

9 analysts · Apr 2026
2
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating

Price Chart

Earnings

Beat rate: 20.0%
Next Report May 11, 2026
EPS Estimate: $-0.20
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.20
Dec 2025 $-0.16 $-0.83 $-0.67
Sep 2025 $-0.30 $-0.65 $-0.35
Jun 2025 $-0.26 $-0.42 $-0.16

Fundamentals Trend

Metric 2024-12-31 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -277.3% -277.3% -277.3% -277.3% -277.3%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 9.99 9.99 9.99 9.99 9.99
Current Ratio 2.33 2.73 2.73 2.73 2.73 2.73

Key Ratios

ROA (TTM)
-269.9%
EPS (TTM)
$-1.71
52W High
$8.94
52W Low
$1.49
$1.49 52-Week Range $8.94

How does MDCX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MDCX AAPG ABEO ABOS ABP

MDCX valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MDCX profitability vs Biotechnology peers

ROE
-277.3%
312% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-269.9%
478% below peers (-46.7%)
vs Peers
vs Industry
Weak

MDCX financial health vs Biotechnology peers

D/E ratio
10.0
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
2.7
38% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
25% below peers (1.0)
vs Peers
vs Industry
More volatile

MDCX fundamentals radar

MDCX Peer median Industry

MDCX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MDCX vs peers: key metrics

Latest News

No related news yet